Expression and purification of recombinant toxic-shock-syndrome toxin I

Jennifer L. Wahlsten, Sundaram Ramakrishnan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Toxic-shock-syndrome toxin I (TSSTI), an exotoxin produced by certain strains of Staphylococcus aureus, has been closely associated with the pathogenesis of toxic shock syndrome. Outside the context of its staphylococcal host, TSSTI may offer therapeutic uses. We report here a strategy for high-level expression and simplified purification of TSSTI. We have subcloned the coding region for TSSTI into a vector containing an inducible T7 promoter sequence and expressed the protein in an Escherichia coli host strain. The recombinant TSSTI protein contained ten sequential histidine residues (Histag) at its N-terminus, which enabled its efficient purification using nickel-agarose-affinity resin. Histag-TSSTI (H-TSSTI) was further purified to homogeneity using a size-exclusion column. By this system, 80 mg of highly purified H-TSSTI can be consistently obtained per litre of culture in under 3 days. H-TSSTI retained biological activity and was unaffected by the presence of the Histag, as measured in lymphocyte proliferation assays.

Original languageEnglish (US)
Pages (from-to)155-159
Number of pages5
JournalBiotechnology and Applied Biochemistry
Volume24
Issue number2
StatePublished - Oct 14 1996
Externally publishedYes

Fingerprint

Poisons
Septic Shock
Purification
Proteins
Lymphocytes
Bioactivity
Escherichia coli
Assays
Resins
Nickel
Exotoxins
Escherichia coli Proteins
Therapeutic Uses
scorpion toxin I''
Staphylococcal enterotoxin F
Histidine
Sepharose
Staphylococcus aureus

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Biotechnology

Cite this

Expression and purification of recombinant toxic-shock-syndrome toxin I. / Wahlsten, Jennifer L.; Ramakrishnan, Sundaram.

In: Biotechnology and Applied Biochemistry, Vol. 24, No. 2, 14.10.1996, p. 155-159.

Research output: Contribution to journalArticle

@article{3c2d11cd5e4e4347851759f7b60dd65c,
title = "Expression and purification of recombinant toxic-shock-syndrome toxin I",
abstract = "Toxic-shock-syndrome toxin I (TSSTI), an exotoxin produced by certain strains of Staphylococcus aureus, has been closely associated with the pathogenesis of toxic shock syndrome. Outside the context of its staphylococcal host, TSSTI may offer therapeutic uses. We report here a strategy for high-level expression and simplified purification of TSSTI. We have subcloned the coding region for TSSTI into a vector containing an inducible T7 promoter sequence and expressed the protein in an Escherichia coli host strain. The recombinant TSSTI protein contained ten sequential histidine residues (Histag) at its N-terminus, which enabled its efficient purification using nickel-agarose-affinity resin. Histag-TSSTI (H-TSSTI) was further purified to homogeneity using a size-exclusion column. By this system, 80 mg of highly purified H-TSSTI can be consistently obtained per litre of culture in under 3 days. H-TSSTI retained biological activity and was unaffected by the presence of the Histag, as measured in lymphocyte proliferation assays.",
author = "Wahlsten, {Jennifer L.} and Sundaram Ramakrishnan",
year = "1996",
month = "10",
day = "14",
language = "English (US)",
volume = "24",
pages = "155--159",
journal = "Biotechnology and Applied Biochemistry",
issn = "0885-4513",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Expression and purification of recombinant toxic-shock-syndrome toxin I

AU - Wahlsten, Jennifer L.

AU - Ramakrishnan, Sundaram

PY - 1996/10/14

Y1 - 1996/10/14

N2 - Toxic-shock-syndrome toxin I (TSSTI), an exotoxin produced by certain strains of Staphylococcus aureus, has been closely associated with the pathogenesis of toxic shock syndrome. Outside the context of its staphylococcal host, TSSTI may offer therapeutic uses. We report here a strategy for high-level expression and simplified purification of TSSTI. We have subcloned the coding region for TSSTI into a vector containing an inducible T7 promoter sequence and expressed the protein in an Escherichia coli host strain. The recombinant TSSTI protein contained ten sequential histidine residues (Histag) at its N-terminus, which enabled its efficient purification using nickel-agarose-affinity resin. Histag-TSSTI (H-TSSTI) was further purified to homogeneity using a size-exclusion column. By this system, 80 mg of highly purified H-TSSTI can be consistently obtained per litre of culture in under 3 days. H-TSSTI retained biological activity and was unaffected by the presence of the Histag, as measured in lymphocyte proliferation assays.

AB - Toxic-shock-syndrome toxin I (TSSTI), an exotoxin produced by certain strains of Staphylococcus aureus, has been closely associated with the pathogenesis of toxic shock syndrome. Outside the context of its staphylococcal host, TSSTI may offer therapeutic uses. We report here a strategy for high-level expression and simplified purification of TSSTI. We have subcloned the coding region for TSSTI into a vector containing an inducible T7 promoter sequence and expressed the protein in an Escherichia coli host strain. The recombinant TSSTI protein contained ten sequential histidine residues (Histag) at its N-terminus, which enabled its efficient purification using nickel-agarose-affinity resin. Histag-TSSTI (H-TSSTI) was further purified to homogeneity using a size-exclusion column. By this system, 80 mg of highly purified H-TSSTI can be consistently obtained per litre of culture in under 3 days. H-TSSTI retained biological activity and was unaffected by the presence of the Histag, as measured in lymphocyte proliferation assays.

UR - http://www.scopus.com/inward/record.url?scp=0029782091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029782091&partnerID=8YFLogxK

M3 - Article

C2 - 8865607

AN - SCOPUS:0029782091

VL - 24

SP - 155

EP - 159

JO - Biotechnology and Applied Biochemistry

JF - Biotechnology and Applied Biochemistry

SN - 0885-4513

IS - 2

ER -